Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (81557)	3/9/2001 2:17:16 PM
From: ChrisJP	Respond to of 150070

Well Jim, its nice to see TALL holding up today. Safer than MSFT, INTC, and CSCO lately. <gg> Chris

To: Jim Bishop who wrote (81557)	6/9/2001 2:37:54 AM
From: wgmnoris	Respond to of 150070

ELTI .08 x .095 1.61M O/S with 334K traded today. Merger? investor.stockpoint.com\151p9289.xml&Mode=&Symbol=elti LAS VEGAS, May 31, 2001 /PRNewswire via COMTEX/ -- ELAST Technologies, Inc. ( OTC BULLETIN BOARD:ELTI) elast.com today announced it has entered into a Letter of Intent with PTS, Inc. and merger negotiations are ongoing. PTS, Inc. is a Nevada corporation organized in 1999. PTS' focus has been the development of a global trading platform designed to facilitate everyday business transactions through the seamless integration of Internet technology. Through its pending joint venture with a Shanghai based information technology firm PTS expects to initiate its global business-to-business platform later this year. ELAST is engaged in the development of two separate diagnostic tools: its allergy testing device and its chiropractic outcome-measuring instrument. The Electronic Allergo Sensitivity Test or the ELAST Device(TM) is a non-invasive medical tool that is being designed to accurately diagnose allergies, as well as food and chemical sensitivities. ELAST Technologies holds the patents, trademarks and legal rights to manufacture and sell and lease its electronic allergy-testing device and is making great strides in refining the prototype. ELAST's Bio-Potential Instrument can provide doctors of chiropractic with the means to measure the damage of vertebral subluxations, as well as the normalizing effect of chiropractic adjustments. ELAST plans initial delivery of its Bio-Potential Instrument shortly. The merger is subject to final negotiation.